Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazufloxacin 0.6% vs Gatifloxacin 0.3% in Acute Bacterial Conjunctivitis
NCT03696342Phase 3Terminated
- Sponsor
- Laboratorios Sophia
- Start
- Oct 2018
- Primary completion
- Mar 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of bpc-157 in bacterial conjunctivitis (BC), sponsored by Laboratorios Sophia. Started Oct 2018; status: terminated.
02
Drugs
bpc-157
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT03696342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03696342.